| 产品详情 |
| Edit |   |
|---|
| Product Name | B. pertussis, Recombinant, Pertactin |
|---|
| Description | Highly Purified (~95%). Pertussis, also known as the whooping cough, is a highly contagious disease caused by the bacterium Bordetella pertussis. Despite generally high coverage with the DTP and DTaP vaccines, pertussis is one of the leading causes of vaccine-preventable deaths world-wide. Ninety percent of all cases occur in the Third World. It is transmitted by airborne infection. B. pertussis vaccine was first developed in 1920 using whole bacterium. In 1942, the whole-cell pertussis vaccine was combined with diphtheria and tetanus toxoids to generate the first DTP combination vaccine. Whole cell vaccines have some side effects. Acellular pertussis vaccine consisting of purified haemagglutinins (HAs: filamentous HA and leucocytosis- promoting-factor HA), which are secreted by B. pertussis into the culture medium are being using alone or in combination with DTaP (aP represents acellular vaccine). The introduction of acellular pertussis (Pa) vaccines in countries with a low uptake of |
|---|
| Size | 10ug |
|---|
| Concentration | n/a |
|---|
| Applications | ELISA WB |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | Accession: CAA06902.2 |
|---|
| Catalog # | 208746 |
|---|
| Price | |
|---|
| Order / More Info | B. pertussis, Recombinant, Pertactin from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|